REQUEST A DEMO
Total
USD $0.00
Search more companies

Restrepo Agudelo Juan Diego (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Restrepo Agudelo Juan Diego Profile Updated: June 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Restrepo Agudelo Juan Diego is based in Colombia. The head office is in Bucaramanga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on May 08, 1987. 1 (2022) employees currently work for Restrepo Agudelo Juan Diego. There was a net sales revenue drop of 50.18% reported in Restrepo Agudelo Juan Diego’s latest financial highlights for 2022. Its total assets grew by 20.65% over the same period. In, 2022, the company’s net profit margin increased by 6381.67%.

Headquarters
Cr 32 # 36-13
Bucaramanga; Santander;

Contact Details: Purchase the Restrepo Agudelo Juan Diego report to view the information.

Website: http://www.lineashospitalarias.com

Basic Information
Total Employees:
Purchase the Restrepo Agudelo Juan Diego report to view the information.
Outstanding Shares:
Purchase the Restrepo Agudelo Juan Diego report to view the information.
Incorporation Date:
May 08, 1987
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Restrepo Agudelo Juan Diego report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-50.18%
Total operating revenue
-50.18%
Net Profit (Loss) for the Period
38.97%
Total assets
20.65%
Total equity
20.52%
Net Profit Margin
6381.67%
Return on Equity (ROE)
3.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?